AstraZeneca

Petition to determine the "fair value" of shares in Gracell Technologies Inc., described as "a global clinical-stage biopharmaceutical company, which is developing cell therapies for the treatment of cancer and autoimmune diseases", at the Grand Court of the Cayman Islands.

Application by Gracell Biotechnologies Inc. to take discovery from Alpine Global Management LLC for use in an "appraisal proceeding" in the Cayman Islands regarding Alpine Partners (BVI) LP's "dissent to the merger between Gracell, Grey Wolf, and AstraZeneca", filed at the U.S. District Court for the Southern District of New York.

Complaint alleging "insider trading by Joublin based on confidential information Joublin obtained while employed at AstraZeneca PLC" in U.S. Securities and Exchange Commission v. Hugues Pierre Joublin, described as a resident of France, at the U.S. District Court for the Southern District of New York.

Class Action Complaint alleging fraud in Alexandre Golovanov v. Innate Pharma S.A., described as being a French company that "purports to be a clinical-stage biotechnology company engaged in discovering and developing first-in-class therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients" and whose securities were listed on NASDAQ; Mondher Mahjoubi, and Laure-Helene Mercieret at the U. S. District Court for the Central District of California.